Alzheimer’s treatment approved in Australia
Kisunla, or Donanemab, by American-based multinational pharmaceutical company Eli Lilly has been approved for use in Australia by the Therapeutic...
Kisunla, or Donanemab, by American-based multinational pharmaceutical company Eli Lilly has been approved for use in Australia by the Therapeutic...
Living a healthy lifestyle could help counteract a genetic risk of developing dementia, new research indicates. Professor Elina Hypponen It’s...
A new research centre in Sydney is hoping to have dementia treatments in clinical trials within five years, thanks to...
Advertisement